A true partner in the pursuit of expanded healthspan
Cambrian’s scientists and company-building experts closely partner with research teams, offering scientific and organizational insights and support for a significant edge in a complex, rapidly evolving field.
The Cambrian model of bringing together expert scientists and experienced company-builders represents an innovative approach to solving complex challenges around the biology of aging.
“Over the next 10 or 15 years, Cambrian wants to bring the way that we treat the diseases of aging into the 21st century by preventing them from happening, instead of waiting for people to get sick, the same way that we learned how to prevent and reverse the pathologies of infectious diseases like smallpox and polio in the 20th century.”
CEO and Founder of Cambrian Biopharma
We combine scientific rigor with an audacious mission: developing transformative, effective and safe therapies to extend healthspan. A crucial aspect of our vision is making these therapies widely available, wherever possible.
"Rational Mind" with Pietro Boselli - Episode 4: Longevity (featuring James Peyer)
"Rational Mind", a science series hosted by engineer and influencer Pietro Boselli, aims to inspire viewers to use rationality and critical thinking to approach complex issues. In this episode, James discusses the longevity science space and the opportunities and challenges ahead.
James Peyer to present at the 8th Aging Research & Drug Discovery Meeting 2021
Dr. James Peyer to present new research in the biology of aging at the world's largest aging research for drug discovery conference.
CogX Festival 2021: "Death is just a Technical Problem" Panel Discussion with James Peyer
"Does anyone really want to live until 180? Progress in longevity science is abundant at the moment, from healthspan hacking to novel therapies being brought under development. Our panel of experts discuss the philosophical and scientific innovations taking place at the cutting edge of the life-extensionists field and what implications they could have for us all." Featuring: James Peyer - CEO - Cambrian Biopharma Peter Ward - Co-founder & CEO - Humanity Inc. Robbie Stamp - CEO - Bioss International Tina Woods - CEO & Founder - Collider Health (Moderator)
PM360: Cambrian is Using a New Drug Discovery Model to Solve the Science of Aging
"Cambrian Biopharma is one of the newly emerging distributed drug discovery companies that applies a new twist to investing in interesting science. PM360 spoke with co-founder James Peyer about this new model, while he decided to focus on the biology of aging, and more."
Foresight Institute Biotech & Health Extension Webinar: “James Peyer: How to Fund and Build Geroprotectors”
"The Foresight Institute is a non-profit organization that was founded in 1986 on a vision of coming revolutions in technology that will bring extraordinary opportunities, as well as unprecedented challenges. Cambrian Biopharma CEO James Peyer led this webinar for their Biotech & Health Extension series, focused on strategies for finding and building geroperotective drugs."